Binding affinity of pyrilutamide!

    Update 4/26/2022
    Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.
    View this post in the Community →

    Similar Community Posts Join

    6 / 727 results

    Related Research

    6 / 8 results